AMCARELAB is a biotechnology and health care company founded in 2015 and headquartered in China. The company's mission is to provide high-quality, clinically reasonable comprehensive diagnostic and consulting services to the population, aiming to achieve precision medicine through personalized diagnostics. Its vision is to lead the global personalized clinical services by innovating healthcare and providing reliable medical knowledge of the genome. The company received a significant CNY200.00M Series B investment on 09 June 2022. The investment was led by Jointown Pharmaceutical Group, Guangdong Technology Financial Group, Kyushu Venture Partners, Bison Capital (China), and CICC Qide. AMCARELAB operates out of its location at Guangzhou International Bio Island, Spiral Fourth Road No.9, Second Floor C201 Unit, Guangzhou, Guangdong Province, China.
广州嘉检医学检测有限公司
使命宣言： •为我们的民众提供高品质的，临床合理的综合诊断和咨询服务，通过个性化诊断实现精准医学。 愿景规划： •通过创新来改善医疗，提供可信赖基因组的医学知识，成为全球个性化临床服务的领先者。
China
27 employees
Series B
Total: $340.00M
Biotechnology, Care Economy +1
General Information
China
BounceWatch is an independent company data service, not affiliated with 广州嘉检医学检测有限公司. To contact 广州嘉检医学检测有限公司, visit amcarelab.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does 广州嘉检医学检测有限公司 compare?
A PDF of 广州嘉检医学检测有限公司 and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting 广州嘉检医学检测有限公司 soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
China Market
Biotechnology
About 广州嘉检医学检测有限公司
Business keywords: medical diagnostics, genetic testing, precision medicine, clinical genetics, clinical biochemistry, molecular genetics, cancer diagnostics, clinical services, innovative healthcare, personalized medicine, biomedical technologies, healthcare improvement, medical knowledge, clinical consultation, diagnostic services
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | CNY200.00M | 6 |
|
09 Jun 2022 |
| Series B | CNY110.00M | 1 |
|
20 Jan 2020 |
| Series A | CNY30.00M | 1 |
|
01 Oct 2019 |
广州嘉检医学检测有限公司 Alternatives & Competitors
View All Alternatives
Genomic and theranostic company specializing in precision medicine for the treatment of cancer and g...
Helping physicians improve outcomes for metastatic cancer patients by delivering advanced diagnostic...
Molecular Diagnostic Solutions for Prostate Cancer
FAQ About 广州嘉检医学检测有限公司
Source: BounceWatch company record for 广州嘉检医学检测有限公司, https://bouncewatch.com/company/amcarelab, updated 21 October 2024. When citing, please name BounceWatch and link this page.
